Predictors of rehospitalization in a naturalistic cohort of patients with bipolar affective disorder
File(s)Predictors of rehospitalisation BD - IJP resub.docx (92.55 KB)
Accepted version
Author(s)
O'Hagan, M
Cornelius, V
Young, AH
Taylor, D
Type
Journal Article
Abstract
There has only been limited research into the predictors of readmission in bipolar disorder. We carried out a 1-year follow-up of patients discharged from a single mental health unit following admission for treatment of an acute bipolar episode. Of 519 patients followed up for 1 year, 167 (32.2%) were readmitted. There was no association between readmission and any drug regimen. Prescription of antidepressants at discharge was not associated with increased risk of readmission [odds ratio (OR): 0.99, 95% confidence interval (CI): 0.98–1.01]. Among demographic factors, only smoking (OR: 1.75, 95% CI: 1.14–2.75) and age range of 42–53 years (OR: 1.99, 95% CI: 1.15–3.43) conferred an increased risk of readmission. Individually optimized drug treatment regimens are equally effective in practice. It is not clear why smoking is associated with readmission.
Date Issued
2017-05-01
Date Acceptance
2017-05-01
Citation
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2017, 32 (3), pp.115-120
ISSN
0268-1315
Publisher
Wolters Kluwer Health, Inc.
Start Page
115
End Page
120
Journal / Book Title
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
Volume
32
Issue
3
Copyright Statement
© 2017 Wolters Kluwer Health, Inc. All rights reserved. This is a non-final version of an article published in final form in International Clinical Psychopharmacology Issue: Volume 32(3), May 2017, p 115–120, available at: https://dx.doi.org/10.1097/YIC.0000000000000163
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398819700001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Pharmacology & Pharmacy
Psychiatry
antidepressants
antipsychotics
bipolar disorder
mood stabilizers
smoking
ADJUNCTIVE ATYPICAL ANTIPSYCHOTICS
MULTIPLE-TREATMENTS METAANALYSIS
TREATMENT-ENHANCEMENT-PROGRAM
RANDOMIZED CONTROLLED-TRIALS
CLAIMS DATABASE ANALYSIS
PSYCHIATRIC-HOSPITALIZATION
COMPARATIVE EFFICACY
MAINTENANCE PHASE
MOOD STABILIZER
SMOKING
1701 Psychology
1115 Pharmacology And Pharmaceutical Sciences
Publication Status
Published